These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease. Nordøy A. Minerva Med; 2002 Oct; 93(5):357-63. PubMed ID: 12410168 [Abstract] [Full Text] [Related]
3. [Treatment of dyslipidemia in the secondary prevention of coronary artery disease]. Syvänne M. Duodecim; 1998 Oct; 114(15):1503-8. PubMed ID: 11552239 [No Abstract] [Full Text] [Related]
10. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)]. Motz W. MMW Fortschr Med; 2003 Oct 09; 145(41):48. PubMed ID: 14655487 [No Abstract] [Full Text] [Related]
12. Rationale for aggressive lipid lowering: evidence from clinical trials. Farmer JA. Expert Rev Cardiovasc Ther; 2004 May 09; 2(3):305-9. PubMed ID: 15151477 [No Abstract] [Full Text] [Related]
13. Summary of the role of statins in the treatment of dyslipidemia. Carr LL. J Am Osteopath Assoc; 2003 Jul 09; 103(7 Suppl 3):S1-3. PubMed ID: 12884937 [No Abstract] [Full Text] [Related]
15. [Hyperlipidemia in patients with ischemic heart disease]. Murase T. Nihon Rinsho; 2001 Mar 09; 59 Suppl 3():722-7. PubMed ID: 11347161 [No Abstract] [Full Text] [Related]
16. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Stone NJ, Bilek S, Rosenbaum S. Am J Cardiol; 2005 Aug 22; 96(4A):53E-59E. PubMed ID: 16098845 [Abstract] [Full Text] [Related]